Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatology, ophthalmology, and oncology; and cereal and milk formula products for infants. It serves patients and medical communities. Dar Al Dawa Development and Investment Co. Ltd. was incorporated in 1975 and is headquartered in Amman, Jordan.
Metrics to compare | DADI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDADIPeersSector | |
---|---|---|---|---|
P/E Ratio | 12.4x | 0.0x | −0.5x | |
PEG Ratio | 0.87 | 0.07 | 0.00 | |
Price/Book | 0.9x | 0.9x | 2.6x | |
Price / LTM Sales | 0.6x | 1.5x | 3.0x | |
Upside (Analyst Target) | - | 70.2% | 53.8% | |
Fair Value Upside | Unlock | 21.6% | 9.6% | Unlock |